A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
OConnor, Timothy, Ph.D. Laboratory Bookmark and Share

Laboratory of Timothy OConnor, Ph.D.

DNA repair is a basic necessary function in all cells, and the mechanisms for repair or damage avoidance are evolutionarily conserved. Cells are constantly subjected to DNA damage from exogenous environmental sources, and also from endogenous oxidative metabolism. Our laboratory is interested in DNA repair mechanisms, the biological consequences of repair failure, and how DNA repair mechanisms can be used to control the epigenome of cells. A complete understanding of DNA repair pathways and the activities of DNA repair proteins can lead to the identification of cellular defects linked to cancer etiology or to targets for tumor therapy.
 
Another more recent area of interest for our laboratory is DNA repair in stem cells. Although stem cells hold great promise in human disease treatment, the DNA repair capabilities must be robust and the genetic stability of cells fully characterized before their use in any regenerative therapy.
 
To address these areas we employ both in vitro and in vivo models to examine:
 
DNA Repair
DNA in cells is constantly exposed to damage from both endogenous and exogenous sources. To remove damage and maintain genomic stability, cells have evolved DNA repair systems. The protein levels in these pathways are finely tuned, and DNA damage may induce production of DNA repair proteins. We study DNA damage and repair from several aspects. Our work involves the study of adducts, the repair enzymes involved in adduct removal, how a repair system functions to remove an adduct, how repair systems interact, and finally the response of cells to DNA damage. One system that we focus on is the base excision repair (BER) pathway replacing mismatched or modified bases in DNA. BER is one of the most important systems in the elimination of endogenous DNA damage. The goal of our research is to understand how DNA repair proteins function to eliminate deleterious adducts from DNA and maintain genomic stability. Our research is divided into several areas.

DNA Repair Enzymology
We have cloned and overproduced numerous DNA repair proteins, and our work in this area continues. We have used the homogeneous proteins to study their biochemical and enzymatic properties. DNA repair proteins are often associated in complexes to facilitate repair. We have recently identified an interaction between two DNA repair proteins involved in the initial steps of both the base and nucleotide excision repair pathways. This interaction could prove critical in directing repair along both pathways. We are currently developing other methods to study these protein-protein interactions.

Regulation of DNA Repair Genes
In response to DNA damage, DNA repair capacity can increase, decrease, or remain unchanged. We are now investigating the response of DNA repair genes to DNA damage at the mRNA, protein, and activity levels. Alteration of the levels of DNA repair proteins can result in a change in the efficiency of a given DNA repair system to remove adducts. This work will serve as the basis for predicting the outcome of different chemo- and radio-therapeutic treatments.

In vivo Repair of DNA Damage
In addition to the study of individual DNA repair enzymes, we are interested in how these enzymes function in cells to excise DNA damage. We are using genomic sequencing techniques, such as ligation-mediated polymerase chain reaction (LMPCR), to follow DNA repair in vivo. We have shown that the repair of methylated bases via BER at nucleotide resolution in normal human cells is heterogeneous and have identified sites of DNA repair footprints. Damage and repair at nucleotide resolution of bases damaged by oxidation and chemotherapeutic agents have also been studied. We are adapting this technique to study the effects of gene therapy agents on the function of DNA repair in human cells.
 
For more information on Dr. O'Connor, please click here.

OConnor, Timothy, Ph.D. Laboratory

Laboratory of Timothy OConnor, Ph.D.

DNA repair is a basic necessary function in all cells, and the mechanisms for repair or damage avoidance are evolutionarily conserved. Cells are constantly subjected to DNA damage from exogenous environmental sources, and also from endogenous oxidative metabolism. Our laboratory is interested in DNA repair mechanisms, the biological consequences of repair failure, and how DNA repair mechanisms can be used to control the epigenome of cells. A complete understanding of DNA repair pathways and the activities of DNA repair proteins can lead to the identification of cellular defects linked to cancer etiology or to targets for tumor therapy.
 
Another more recent area of interest for our laboratory is DNA repair in stem cells. Although stem cells hold great promise in human disease treatment, the DNA repair capabilities must be robust and the genetic stability of cells fully characterized before their use in any regenerative therapy.
 
To address these areas we employ both in vitro and in vivo models to examine:
 
DNA Repair
DNA in cells is constantly exposed to damage from both endogenous and exogenous sources. To remove damage and maintain genomic stability, cells have evolved DNA repair systems. The protein levels in these pathways are finely tuned, and DNA damage may induce production of DNA repair proteins. We study DNA damage and repair from several aspects. Our work involves the study of adducts, the repair enzymes involved in adduct removal, how a repair system functions to remove an adduct, how repair systems interact, and finally the response of cells to DNA damage. One system that we focus on is the base excision repair (BER) pathway replacing mismatched or modified bases in DNA. BER is one of the most important systems in the elimination of endogenous DNA damage. The goal of our research is to understand how DNA repair proteins function to eliminate deleterious adducts from DNA and maintain genomic stability. Our research is divided into several areas.

DNA Repair Enzymology
We have cloned and overproduced numerous DNA repair proteins, and our work in this area continues. We have used the homogeneous proteins to study their biochemical and enzymatic properties. DNA repair proteins are often associated in complexes to facilitate repair. We have recently identified an interaction between two DNA repair proteins involved in the initial steps of both the base and nucleotide excision repair pathways. This interaction could prove critical in directing repair along both pathways. We are currently developing other methods to study these protein-protein interactions.

Regulation of DNA Repair Genes
In response to DNA damage, DNA repair capacity can increase, decrease, or remain unchanged. We are now investigating the response of DNA repair genes to DNA damage at the mRNA, protein, and activity levels. Alteration of the levels of DNA repair proteins can result in a change in the efficiency of a given DNA repair system to remove adducts. This work will serve as the basis for predicting the outcome of different chemo- and radio-therapeutic treatments.

In vivo Repair of DNA Damage
In addition to the study of individual DNA repair enzymes, we are interested in how these enzymes function in cells to excise DNA damage. We are using genomic sequencing techniques, such as ligation-mediated polymerase chain reaction (LMPCR), to follow DNA repair in vivo. We have shown that the repair of methylated bases via BER at nucleotide resolution in normal human cells is heterogeneous and have identified sites of DNA repair footprints. Damage and repair at nucleotide resolution of bases damaged by oxidation and chemotherapeutic agents have also been studied. We are adapting this technique to study the effects of gene therapy agents on the function of DNA repair in human cells.
 
For more information on Dr. O'Connor, please click here.
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.

Learn more about
City of Hope's institutional distinctions, breakthrough innovations and collaborations.
 
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • The outlook and length of survival has not changed much in the past 25 years for patients suffering from an aggressive form of pancreatic cancer known as pancreatic ductal adenocarcinoma (PDAC). These patients still have few options for therapy; currently available therapies are generally toxic and do not incre...
  • “With bladder cancer, the majority of patients that I see can be cured,” said urologist Kevin Chan, M.D., head of reconstructive urology at City of Hope. “The challenge is to get patients the same quality of life that they had before surgery.” To meet this challenge, Chan and the urologic team at City of Hope [...
  • Already pioneers in the use of immunotherapy, City of Hope researchers are now testing the bold approach to cancer treatment against one of medicine’s biggest challenges: brain cancer. This month, they will launch a clinical trial using patients’ own modified T cells to fight advanced brain tumors. One of but a...
  • Brain cancer may be one of the most-frightening diagnoses people can receive, striking at the very center of who we are as individuals. Further, it often develops over time, causing no symptoms until it’s already advanced. Listen to City of Hope Radio as Behnam Badie, M.D., director of the Brain Tumor Pro...
  • The whole is greater than the sum of its parts. It takes a village. No man is an island. Choose your aphorism: It’s a simple truth that collaboration usually is better than isolation. That’s especially true when you’re trying to introduce healthful habits and deliver health care to people at risk of disease and...
  • When Maryland Governor Larry Hogan announced earlier this week that he has the most common form of non-Hodgkin lymphoma, he was giving voice to the experience of more than 71,000 Americans each year. The announcement came with Hogan’s promise to stay in office while undergoing aggressive treatment for the...
  • The spine can be affected by many different kinds of tumors. Malignant, or cancerous, tumors can arise within the spine itself. Secondary spinal tumors, which are actually much more common, begin as cancers in another part of the body, such as the breast and prostate, and then spread, or metastasize, to the spi...
  • Although most cancer occurs in older adults, the bulk of cancer research doesn’t focus on this vulnerable and fast-growing population. City of Hope and its Cancer and Aging Research Team aim to change that, and they’re getting a significant boost from Professional Practice Leader Peggy Burhenn, R.N....
  • Liz Graef-Larcher’s first brain tumor was discovered by accident six years ago. The then-48-year-old with a long history of sinus problems and headaches had been sent for an MRI, and the scan found a lesion in her brain called a meningioma – a tumor that arises in the meninges, the layers of tissue that cover a...
  • The colon and rectum are parts of the body’s gastrointestinal system, also called the digestive tract. After food is digested in the stomach and nutrients are absorbed in the small intestine, the remaining material moves down into the lower large intestine (colon) where water and nutrients are absorbed. The low...
  • If there is one truism about hospital stays it is that patients want to get out. For many, however, the joy of being discharged is tempered by the unexpected challenges that recovery in a new setting may pose. Even with professional help, the quality of care and treatment that patients receive at City of Hope [...
  • Jana Portnow, M.D., associate director of the Brain Tumor Program at City of Hope, didn’t expect to specialize in treating brain tumors. But, early in her career, she undertook a year of research on pain management and palliative care and, in that program, got to know many patients with brain tumors. After that...
  • Ask any patient: Nurses are as pivotal in their care as doctors. They answer the call of a patient in the middle of the night, they hold the patient’s hand as he or she takes on yet another round of treatment and, in the best-case scenario, they wave goodbye as the patient leaves the hospital, […]
  • Many oncologists, not to mention their patients, might think that there’s no place for mathematical analysis in the treatment of cancer. They might think that all treatment decisions are based on unique factors affecting individual patients, with no connection to other patients and their treatment regimen...
  • Within three days in 2007, Stephanie Hosford, then 37, learned that she was pregnant with her long-awaited second child – and that she had triple-negative breast cancer. Soon afterward, Hosford discovered that she and her husband, Grant, had been approved to adopt a little girl from China.  After encountering m...